Clinical Trials

We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.

Patient fatality reported in clinical trial for investigational gene therapy for Danon disease.

Researchers conduct small phase I study on placenta-derived stem cell therapy to treat a serious form of multiple sclerosis

The industry has spent decades optimizing distribution strategies to meet faster timelines. Now, it’s time to think about sustainability.

Can digital tools help lower the carbon footprint of a clinical trial? First, we need more data.

Gene therapy clinical trial shows striking outcomes in children with rare and often fatal immune disorder.

Can making clinical trials more family friendly help increase the number of female participants?

Our latest news roundup reports on Amgen’s $900 million investment, EMA’s re-examination of donanemab, philanthropy at Sanofi, and more.

Non-clinical toxicology study of investigational drug for psoriasis reveals worrying results.

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.